NCT06788327 (S-TRONGER) is a NA clinical trial of Standard rehabilitation in Rotator Cuff Injury, sponsored by University of Valencia.

Who is sponsoring NCT06788327?

NCT06788327 is sponsored by University of Valencia.

What drugs are being tested in NCT06788327?

Interventions in NCT06788327: Standard rehabilitation, Blood Flow Restriction Therapy.

What condition does NCT06788327 study?

NCT06788327 studies Rotator Cuff Injury, Rotator Cuff Tears, Rotator Cuff Repair.

Is NCT06788327 still recruiting?

NCT06788327 is currently not yet recruiting. Last updated 23 January 2025.

Last reviewed 2025-01-23 · How we verify

NCT06788327: S-TRONGER

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Blood Flow Restriction Versus Standard Exercise After Rotator Cuff Repair

Not yet recruiting NA Last updated 23 January 2025

What this trial tests

NA trial testing Standard rehabilitation in Rotator Cuff Injury in 50 participants. Not yet recruiting.

Timeline

3 March 2025

Primary endpoint
31 December 2026

31 August 2027

Quick facts

Lead sponsor	University of Valencia
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	50
Start date	3 March 2025
Primary completion	31 December 2026
Estimated completion	31 August 2027
Sites	1 location across Chile

Drugs / interventions tested

Standard rehabilitation
Blood Flow Restriction Therapy

Conditions studied

Rotator Cuff Injury — all drugs for Rotator Cuff Injury →
Rotator Cuff Tears — all drugs for Rotator Cuff Tears →
Rotator Cuff Repair — all drugs for Rotator Cuff Repair →

Sponsor

University of Valencia

Who can join

Adults 40 to 65, any sex, with Rotator Cuff Injury or Rotator Cuff Tears. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to determine the effectiveness of postoperative standard exercises with blood flow restriction therapy (BFRT) versus standard exercises alone on shoulder muscle strength and mass in participants with surgically treated rotator cuff tear. It is presumed that the addition of BFRT will significantly improve the shoulder strength and muscle mass at the end of the intervention period compared to the group receiving only standard exercises. Patients who agree to participate in this research will be randomly assigned to a control group (standard exercises alone) or an experimental group (standard rehabilitation with BFRT). The duration of the postoperative intervention will be 12 weeks. The primary variables will be the shoulder muscle strength and muscle mass. Secondary variables will be the active shoulder mobility, pain intensity, upper limb disability, and health-related quality of life. Results will be measured at 0, 4 and 12 weeks postoperative.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Standard rehabilitation

Trials testing the same drug.

NCT07456306 — Artificial Intelligence-Driven Virtual Reality Rehabilitation for Upper Limb Recovery in Acute and Subacute Stroke Patie · NA · not yet recruiting
NCT07321483 — Reflex Therapy of Temporomandibular Dysfunctions · NA · recruiting
NCT06780319 — Digital Rehabilitation After Hip Arthroplasty: a Randomized Controlled Trial · NA · recruiting
NCT07080814 — The Effect of Balance Training Using a Dynamometric Platform in Patients Undergoing Total Knee Arthroplasty · NA · recruiting
NCT06814821 — Web-based Rehabilitation After Surgical Salvage Procedures for Wrist Osteoarthritis · NA · not yet recruiting

Other recruiting trials for Rotator Cuff Injury

Currently open trials in the same condition.

NCT07005063 — Rotator Cuff Tendon Repair With FiberLocker System Patch Augmentation · NA · recruiting
NCT06774820 — Self-locking Tenodesis of the Long Chief of the Biceps Vs. Lasso 360 Tenodesis in Arthroscopic Rotator Cuff Repair Rotat · NA · recruiting

Other University of Valencia trials

Trials by the same sponsor.

NCT07509281 — Peri-implant Tissues Changes for Different Abutment Shapes and Heights · NA · not yet recruiting
NCT07535528 — Implant Placement Depth and Peri-Implant Tissue Outcomes · NA · not yet recruiting
NCT07471555 — Vascular Access and Intraosseus · NA · enrolling by invitation
NCT07463066 — Long-Term Effectiveness of Pain Neuroscience Education in Women With Genito-Pelvic Pain/Penetration Disorder. · not yet recruiting
NCT07419399 — Acute Effects of Radiofrequency Diathermy in Postpartum Women With Diastasis Abdominis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06788327 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Valencia
Last refreshed: 23 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06788327.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing